Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001100412-19-000021
Filing Date
2019-05-07
Accepted
2019-05-07 08:14:58
Documents
70
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a03311910-q.htm 10-Q 1399650
2 EXHIBIT 5.1 skaddenatmopinion.htm EX-5.1 16515
3 EXHIBIT 10.1 oltmansseparation.htm EX-10.1 35491
4 EXHIBIT 10.2 jefferiessalesagmt.htm EX-10.2 330110
5 EXHIBIT 31.1 a033119ex311.htm EX-31.1 14798
6 EXHIBIT 31.2 a033119ex312.htm EX-31.2 14045
7 EXHIBIT 32.1 a033119ex321.htm EX-32.1 11763
14 arraylogo2018a15.jpg GRAPHIC 146580
15 braftovimektovirrgba02.jpg GRAPHIC 224279
  Complete submission text file 0001100412-19-000021.txt   8621220

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT arry-20190331.xml EX-101.INS 1821671
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arry-20190331.xsd EX-101.SCH 50158
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT arry-20190331_cal.xml EX-101.CAL 72352
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT arry-20190331_def.xml EX-101.DEF 332190
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arry-20190331_lab.xml EX-101.LAB 692864
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arry-20190331_pre.xml EX-101.PRE 442177
Mailing Address 3200 WALNUT STREET BOULDER CO 80301
Business Address 3200 WALNUT STREET BOULDER CO 80301 3033816600
ARRAY BIOPHARMA INC (Filer) CIK: 0001100412 (see all company filings)

EIN.: 841460811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-16633 | Film No.: 19801350
SIC: 2834 Pharmaceutical Preparations